ARES is scheduled to report Q4 earnings on Feb. 5, with higher AUM, rising revenues and recent acquisitions shaping expectations despite expense...

TROW's Q4 results, scheduled for Feb. 4, are expected to reflect higher earnings and revenues, backed by AUM growth despite net outflows and expense...

Alamos Gold reports Q4 results on Feb. 18, with earnings seen surging 96% YoY as record revenues and higher gold prices offset production hiccups.

Alamos Gold reports Q4 results on Feb. 18, with earnings seen surging 96% YoY as record revenues and higher gold prices offset production hiccups.

EXPE heads into Q4 earnings with revenues seen up nearly 7%, strong B2B and ad momentum, plus AI launches and a Tiqets deal in focus.

Select Medical heads into Q4 earnings with EPS expected to be up 27.8% and revenues rising 3.7%, as key segments show growth.

Select Medical heads into Q4 earnings with EPS expected to be up 27.8% and revenues rising 3.7%, as key segments show growth.

HAS Q4 earnings and revenues beat estimates, shares rise premarket as Wizards of the Coast fueled growth and management highlights a strong 2025.

TER tops Q4 expectations as demand strength lifted revenue and earnings, sending the stock sharply higher in pre-market trading.

IPGP beat Q4 estimates as revenues rise 17% Y/Y, driven by industrial demand and growth products, sending shares sharply higher.